Read + Share
Amedeo Smart
Independent Medical Education
Imel EA, Starzyk K, Gliklich R, Weiss RJ, et al. Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis. Osteoporos Int 2020;31:2413-2424.PMID: 32696118
Email
LinkedIn
Facebook
Twitter
Privacy Policy